Follow us to discover the latest in the legal world.

Losartan Blood Pressure Medication Recall

Case Updates

  • March 22, 2019 — Notice of Civil Claim was filed.



On March 12, 2019, Hammerco Lawyers filed a proposed class action against PRO DOC LIMITEE, APOTEX INC., PHARMASCIENCE INC. and TEVA CANADA LIMITED defendants alleging the Defendants supplied and/or distributed Losartan that was contaminated with a carcinogen.

The misrepresentations by the Defendants as to the risks associated with the use of the Losartan Drugs constitute unlawful, unfair, and deceptive trade practices.